ArticleLeukemia2022
JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Aissa Benyoucef et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleLeukemia2022
Aissa Benyoucef et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.